Epiq Partners, LLC Impel Pharmaceuticals Inc Transaction History

Epiq Partners, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2023 Oct 18, 2023	SELL	$0.31 - $1.75 $719 - $4,061	-2,321 Reduced 12.45%	16,325 $7,000
Q4 2021 Jan 25, 2022	BUY	$8.33 - $12.14 $155,321 - $226,362	18,646 New	18,646 $161,000

14.4K

Ticker IMPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,738,800
Market Cap $475K
Description
Impel Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for patients suffering from central nervous system disease in the United States. Its lead product candidate is Trudhesa, an upper nasal formulation of dihydroergotamine for the acute treatment of migraine. The c...

Get notified when there are updates to the investment portfolio of Epiq Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Epiq Partners, LLC with notifications on news.